secwatch.observer — SEC 8-K summary
======================================

Issuer:     Intellia Therapeutics, Inc. (NTLA)
CIK:        0001652130
Form:       8-K
Filed at:   2022-12-01T23:59:59+00:00
Accession:  0001193125-22-296686
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intellia raises ~$293.5M in public offering of 6.55M shares at $45.80
---------------------------------------------------------------------

- Offering of 6,550,219 shares of common stock at $45.80 per share; underwriter option for up to 982,532 additional shares.
- Net proceeds estimated at $293.5M after underwriting discount and expenses; expected close December 2, 2022.
- Underwriting agreement with Goldman Sachs & Co. LLC; customary representations and indemnification provisions.
- Offering conducted under existing shelf registration statement (File No. 333-251022); prospectus supplement dated November 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652130/000119312522296686/0001193125-22-296686-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652130/000119312522296686/d358556d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-296686

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer